Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of liraglutide on insulin-associated weight gain in type 2 diabetes
2011-000411-12Phase 4Completed
- Sponsor
- Radboud University Medical Center
- Start
- Nov 2011
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, single-arm trial of liraglutide in type 2 diabetes mellitus (T2DM), sponsored by Radboud University Medical Center. Primary endpoint: Change in body weight. Started Nov 2011; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2011-000411-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000411-12.